Log in to save to my catalogue

POS0623 INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTER...

POS0623 INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTER...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2856490328

POS0623 INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTERIZE NEW BIOMARKERS ASSOCIATED TO RELEVANT PATHOLOGICAL FEATURES

About this item

Full title

POS0623 INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTERIZE NEW BIOMARKERS ASSOCIATED TO RELEVANT PATHOLOGICAL FEATURES

Publisher

Kidlington: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.585-585

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Limited

More information

Scope and Contents

Contents

BackgroundSystemic sclerosis (SSc) is a heterogeneous multisystemic autoimmune disease, characterized by extensive skin fibrosis, vascular abnormalities, and autoantibodies against various cellular antigens. The integrated analysis of proteomic and metabolomic in SSc might shed light in the pathogenesis of the disease and reveal novel biomarkers.Ob...

Alternative Titles

Full title

POS0623 INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTERIZE NEW BIOMARKERS ASSOCIATED TO RELEVANT PATHOLOGICAL FEATURES

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2856490328

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2856490328

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2023-eular.3648

How to access this item